[(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate
[(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate
PubChem CID: 54675769
Novobiocin is a coumarin-derived antibiotic obtained from Streptomyces niveus. It has a role as an antimicrobial agent, an antibacterial agent, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a hepatoprotective agent and an Escherichia coli metabolite. It is a carbamate ester, an ether, a monocarboxylic acid amide, a member of phenols, a hexoside, a hydroxycoumarin and a monosaccharide derivative. It is a conjugate acid of a novobiocin(1-).
Canonical SMILES
SMILES: This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to novobiocin